Ambev S.A. (ABEV) belonging to the Consumer Defensive sector has declined -2.05% and closed its last trading session at $6.21.
The company reported its EPS on 9/29/2017. Currently, the stock has a 1 Year Price Target of $6.98.
The consensus recommendation, according to Zacks Investment research, is 2.33. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 2.33 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.33 and 2.5 respectively.
Ambev S.A. on 9/29/2017 reported its EPS as $0.09 with the analysts projecting the EPS of the stock as $0.08. The company beat the analyst EPS Estimate with the difference of $0.01. This shows a surprise factor of 0.125%.
Many analysts have provided their estimated foresights on Ambev S.A. Earnings, with 4 analysts believing the company would generate an Average Estimate of $0.08.
Whereas they predicted High and Low Earnings Estimate as $0.1 and $0.07 respectively. While in the same Quarter Previous year, the Actual EPS was $0.09.
Analysts are also projecting an Average Revenue Estimate for Ambev S.A. as $4.54 Million in the Current Quarter. This estimate is provided by 1 analysts.
The High Revenue estimate is predicted as 4.54 Million, while the Low Revenue Estimate prediction stands at 4.54 Million. The company’s last year sales total was 4 Million.
For the Current Quarter, the growth estimate for Ambev S.A. is -11.1%, while for the Next Quarter the stock growth estimate is 20%.
In the past 5 years, the stock showed growth of -19.1% per annum. While for the next 5 years, the growth estimate is 4.43%.
Ambev S.A. (ABEV) has the market capitalization of $97.55 Billion. The company rocked its 52-Week High of $7.03 and touched its 52-Week Low of $4.73.
The stock is currently showing YTD performance of 26.48 Percent. The company has Beta Value of 0 and ATR value of 0.13. The Weekly and Monthly Volatility stands at 2.11% and 1.83%.